Oncologic Emergencies: TLS Flashcards

1
Q

TLS definition

A

Large number of cancer cells dies within a short period and cell contents are released into the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Electrolyte disturbances in TLS

A

Hyperkalemia
Hyperphosphatemia
Hypocalcemia
Hyperuricemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Lab TLS

A

≥2 electrolyte abnormalities within 3 days before or 7 days after treatment initiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hyperkalemia definition

A

≥6.0 mEq/L

ECG abnormalities, cardiac arrest, fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hyperuricemia definition

A

≥8.0 mEq/L

AKI, crystal neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hyperphosphatemia definition

A

≥4.5 mEq/L

AKI, GI upset, AMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hypocalcemia definition

A

≤7.0 mg/dl

AMS, seizures, arrhythmias, tetany, spasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical TLS definition

A

Presence of lab TLS plus AKI, seizures or neuromuscular irritability, cardiac arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cancer-related TLS risk factors

A

high proliferation rate, tumor bulk, circulating tumor cells, sensitivity to cytotoxic therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Patient-specific TLS risk factors

A

elevated baseline uric acid, nephropathy, hydration status, hypotension, acidic urine, LV dysfunction/HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

TLS prevention

A

Hold causative agents: diuretics, calcium/potassium/phosphate-containing supplements and nutritional products, ACEis, nephrotoxic agents

Hydration: IV NS, avoid adding bicarb

Risk-based prevention: based on low, intermediate, high risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Low risk for TLS

A

Observation, normal hydration, monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Intermediate risk for TLS

A

Hydration, allopurinol, consider rasburicase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

High risk for TLS

A

Hydration, rasburicase, allopurinol

(Dialysis if refractory to rasburicase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Indications for dialysis

A

refractory volume overload, oliguria, or anuria; persistent hyperkalemia or hyperuricemia, hyperphosphatemia-induced symptomatic hypocalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hyperkalemia treatment

A

Hydration, use diuretics to optimize urine output

Calcium chloride 1g IV
Regular insulin 10 units PLUS IV dextrose 25g
Sodium bicarb 50 mEq IV
SPS 15-60g PO
Hemodialysis or CRRT

17
Q

Hyperphosphatemia treatment

A

First-line is IV hydration
Restrict dietary intake to 800-1000mg/day
Phosphate binders
Last-line: dialysis

18
Q

Phosphate binders

A

Calcium acetate
Calcium carbonate
Aluminum hydroxide
Lanthanum
Sevelamer

19
Q

Hypocalcemia treatment

A

Typically resolves with Hyperphosphatemia treatment, only treat symptomatic hypocalcemia to avoid overcorrection (cardiac arrhythmias, seizures, tetany)

20
Q

Indication for allopurinol in TLS

A

Patients at risk for developing TLS
Initiate 24hrs prior to chemo

21
Q

Allopurinol cautions

A

Drug interactions, severe hypersensitivity

22
Q

Rasburicase indication in TLS

A

Suitable for patients with preexisting hyperuricemia before treatment, those at high risk for TLS, or patients with spontaneous TLS

23
Q

Rasburicase cautions

A

G6PD deficiency
Cost (super expensive)